The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Open accessAbstract
Otto Warburg's theory on the origins of cancer postulates that tumor cells have defects in mitochondrial oxidative phosphorylation and therefore rely on high levels of aerobic glycolysis as the major source of ATP to fuel cellular proliferation (the Warburg effect). This is in contrast to normal cells, which primarily utilize oxidative phosphorylation for growth and survival. Here we report that the major function of glucose metabolism for Kras-induced anchorage-independent growth, a hallmark of transformed cells, is to support the pentose phosphate pathway. The major function of glycolytic ATP is to support growth under hypoxic conditions. Glutamine conversion into the tricarboxylic acid cycle intermediate alpha-ketoglutarate through glutaminase and alanine aminotransferase is essential for Kras-induced anchorage-independent growth. Mitochondrial metabolism allows for the generation of reactive oxygen species (ROS) which are required for Kras-induced anchorage-independent growth through regulation of the ERK MAPK signaling pathway. We show that the major source of ROS generation required for anchorage-independent growth is the Q o site of mitochondrial complex III. Furthermore, disruption of mitochondrial function by loss of the mitochondrial transcription factor A (TFAM) gene reduced tumorigenesis in an oncogenic Kras-driven mouse model of lung cancer. These results demonstrate that mitochondrial metabolism and mitochondrial ROS generation are essential for Kras-induced cell proliferation and tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Providing cells with αKG, oxaloacetate, or pyruvate is sufficient to rescue cancer cell proliferation in conditions of glutamine starvation, confirming that glutamine supports proliferation by replenishing depleted TCA cycle intermediates, a process termed anaplerosis (Altman et al., 2016; Weinberg et al., 2010; Yuneva et al., 2007).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Weinberg et al., 2010
In the citing paper
“However, KRAS has also been shown to promote cancer cell growth by stimulating alanine aminotransferase activity, leading to high levels of α-ketoglutarate for the TCA cycle and mitochondrial ROS generation, which was required for mutant KRAS-driven tumorigenesis in a mouse model of lung cancer64.”
From The metabolic landscape of RAS-driven cancers from biology to therapy (2021) · cites this paper as [64]
In the citing paper
“A low level of reactive oxygen species (ROS) activates tumorigenic growth signaling; however, when the level exceeds the cellular redox capacity, ROS can damage macromolecules such as proteins, lipids and nucleotides55.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [55]
In the citing paper
“Correspondingly, in K-Ras mutant cells, the oxygen consumption rate and ATP generation are enhanced by glutamine, contributing to tumorigenesis55.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [55]
In the citing paper
“Notably, alanine levels were significantly decreased in Mpc knockdown cells, highlighting a role for mitochondrial pyruvate and mitochondrial alanine aminotransferase (ALT2) in mediating glutamine anaplerosis which was previously described in cancer cells (Weinberg et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Weinberg et al., 2010
In the citing paper
“Another study reported that mitochondrial ROS are necessary for the KRAS (Kirsten rat sarcoma virus)—induced anchored-independent growth of lung cancer.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Weinberg et al. 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,001
Redox control of glutamine utilization in cancer
Alberghina, L., & Gaglio, D. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.513 · Cited by 150
Chinopoulos, C. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23196 · Cited by 148
Rohlenová, K., Sachaphibulkij, K., Štursa, J., Bezawork‐Geleta, A., Blecha, J., Endaya, B., Werner, L., Černý, J., Zobalová, R., Goodwin, J., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6677 · Cited by 144
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 147
Cheng, C.-W., Kuo, C.-Y., Fan, C.-C., Fang, W.-C., Jiang, S. S., Yk, L., Wang, T.-Y., Kao, M.-C., & Lee, A. Y.-L. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.204 · Cited by 142
DNA Damage in Cancer Therapeutics: A Boon or a Curse?
Khanna, A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3247 · Cited by 142
Kalyanaraman, B., Hardy, M., Podsiadły, R., Cheng, G., & Zielonka, J. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.08.021 · Cited by 140
Self-citationMitochondrial Genome Instability and ROS Enhance Intestinal Tumorigenesis in APC Mice
Woo, D. K., Green, P. D., Santos, J. H., D’Souza, A. D., Walther, Z., Martin, W. D., Christian, B. E., Chandel, N. S., & Shadel, G. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.003 · Cited by 138
Self-citationMitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
Ishimoto, Y., Inagi, R., Yoshihara, D., Kugita, M., Nagao, S., Shimizu, A., Takeda, N., Wake, M., Honda, K., Zhou, J., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00337-17 · Cited by 139
Using Seahorse Machine to Measure OCR and ECAR in Cancer Cells
Zhang, J., & Zhang, Q. H. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9027-6_18 · Cited by 140
A break in mitochondrial endosymbiosis as a basis for inflammatory diseases
Murphy, M. P., & O’Neill, L. A. J. (2024) · Nature · doi:10.1038/s41586-023-06866-z · Cited by 138
Obre, E., & Rossignol, R. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.12.008 · Cited by 137
Balliet, R. M., Capparelli, C., Guido, C., Pestell, T. G., Martinez‐Outschoorn, U., Zhao, L., Whitaker‐Menezes, D., Chiavarina, B., Pestell, R. G., Howell, A., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18254 · Cited by 138
The many faces of Janus kinase
Seavey, M. M., & Dobrzański, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.024 · Cited by 136
Biochemical Underpinnings of Immune Cell Metabolic Phenotypes
Olenchock, B. A., Rathmell, J. C., & Heiden, M. G. V. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.013 · Cited by 141
Targeting mitochondria in cancer: current concepts and immunotherapy approaches
Pustylnikov, S., Costabile, F., Beghi, S., & Facciabene, A. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.013 · Cited by 142
CRISPR screens in physiologic medium reveal conditionally essential genes in human cells
Rossiter, N. J., Huggler, K. S., Adelmann, C. H., Keys, H. R., Soens, R. W., Sabatini, D. M., & Cantor, J. R. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.005 · Cited by 138
Cancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 140
Glutamine metabolism in breast cancer and possible therapeutic targets
Li, S., Zeng, H., Fan, J., Wang, X., Xu, C., Li, Y., Tu, J., Nephew, K. P., & Long, X. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115464 · Cited by 143
Targeting metabolic reprogramming in KRAS-driven cancers
Kawada, K., Toda, K., & Sakai, Y. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1156-4 · Cited by 140
Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
Uras, I. Z., Moll, H. P., & Casanova, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124325 · Cited by 138
Mitochondrial fission‐fusion as an emerging key regulator of cell proliferation and differentiation
Mitra, K. (2013) · BioEssays · doi:10.1002/bies.201300011 · Cited by 134
Hopefully devoted to Q: targeting glutamine addiction in cancer
Still, E. R., & Yuneva, M. O. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.113 · Cited by 142
Ren, Y., Wang, R., Weng, S., Xu, H., Zhang, Y., Chen, S., Liu, S., Ba, Y., Zhou, Z., Luo, P., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01831-w · Cited by 149
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance
Belisario, D. C., Kopecka, J., Pasino, M., Akman, M., De Smaele, E., Donadelli, M., & Riganti, C. (2020) · Cells · doi:10.3390/cells9122598 · Cited by 133
Mitochondria in cancer: at the crossroads of life and death
Fogg, V. C., Lanning, N. J., & MacKeigan, J. P. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10018 · Cited by 139
Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Cancer
Gao, L., Loveless, J., Shay, C., & Teng, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_1 · Cited by 135
Diers, A. R., Broniowska, K. A., Chang, C.-F., & Hogg, N. (2012) · Biochemical Journal · doi:10.1042/bj20120294 · Cited by 133
Cheng, G., Zielonka, J., McAllister, D. M., Mackinnon, A. C., Joseph, J., Dwinell, M. B., & Kalyanaraman, B. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-285 · Cited by 132
Self-citationHe, Z., Xu, Q., Newland, B., Foley, R., Lara‐Sáez, I., Curtin, J. F., & Wang, W. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00728a · Cited by 134
Metabolic alterations in cancer cells and therapeutic implications
Hammoudi, N., Ahmed, K. B. R., Garcı́a-Prieto, C., & Huang, P. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10267 · Cited by 137
The PI3K, Metabolic, and Autophagy Networks: Interactive Partners in Cellular Health and Disease
Shanware, N. P., Bray, K., & Abraham, R. T. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134717 · Cited by 136
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
Yamada, Y., Satrialdi, S., Hibino, M., Sasaki, D., Abe, J., & Harashima, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.010 · Cited by 129
Dong, C., Dai, X., Wang, X., Lu, Q., Chen, L., Song, X., Ding, L., Huang, H., Feng, W., Chen, Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202205680 · Cited by 130
Metabolic reprogramming and its clinical implication for liver cancer
Yang, F., Hilakivi-Clarke, L. A., Shaha, A., Wang, Y., Wang, X., Deng, Y., Lai, J., & Kang, N. (2023) · Hepatology · doi:10.1097/hep.0000000000000005 · Cited by 140
Chinopoulos, C., & Seyfried, T. N. (2018) · ASN NEURO · doi:10.1177/1759091418818261 · Cited by 130
Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
Rasola, A., Neckers, L., & Picard, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.005 · Cited by 129
Metabolic Remodeling during Liver Regeneration
Caldez, M. J., Van Hul, N., Koh, H. W. L., Teo, X. Q., Fan, J. J., Tan, P. Y., Dewhurst, M. R., Too, P. G., Talib, S. Z. A., Chiang, B. E., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.09.020 · Cited by 133
Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response
Zhang, L., Wang, K., Lei, Y., Li, Q., Nice, E. C., & Huang, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.030 · Cited by 127
Increased Oxidative Metabolism in the Li–Fraumeni Syndrome
Wang, P., Ma, W., Park, J., Celi, F. S., Arena, R. A., Choi, J. W., Ali, Q. A., Tripodi, D., Zhuang, J., Lago, C. U., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214091 · Cited by 128
Amplification of USP13 drives ovarian cancer metabolism
Han, C., Yang, L., Choi, H. H., Baddour, J., Achreja, A., Liu, Y., Li, Y., Li, J., Wan, G., Huang, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13525 · Cited by 127
Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
Thompson, R. M., Dytfeld, D., Reyes, L., Robinson, R. M., Smith, B. M., Manevich, Y., Jakubowiak, A. J., Komarnicki, M. A., Przybyłowicz-Chalecka, A., Szczepaniak, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16262 · Cited by 126
Koundinya, M., Sudhalter, J., Courjaud, A., Lionne, B., Touyer, G., Bonnet, L., Menguy, I., Schreiber, I., Perrault, C., Vougier, S., et al. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.03.005 · Cited by 123
Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation
Boyle, K. A., Wickle, J. V., Hill, R. B., Marchese, A., Kalyanaraman, B., & Dwinell, M. B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001469 · Cited by 130
Self-citationOshima, N., Ishida, R., Kishimoto, S., Beebe, K. E., Brender, J., Yamamoto, K., Urban, D. J., Rai, G., Johnson, M. S., Benavides, G. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.039 · Cited by 130
On the Origin of ATP Synthesis in Cancer
Seyfried, T. N., Arismendi-Morillo, G., Mukherjee, P., & Chinopoulos, C. (2020) · iScience · doi:10.1016/j.isci.2020.101761 · Cited by 121
Brand, M. D. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828258 · Cited by 123
Wang, Y., Wang, F., Wang, L., Qiu, S., Yao, Y., Yan, C., Xiong, X., Chen, X., Ji, Q., Cao, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109516 · Cited by 125
Redox Regulation in Cancer Cells during Metastasis
Tasdogan, A., Ubellacker, J. M., & Morrison, S. J. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0558 · Cited by 129
The Role of Oxidative Stress in Tumorigenesis and Progression
Li, K., Deng, Z., Lei, C., Ding, X., Li, J., & Wang, C. (2024) · Cells · doi:10.3390/cells13050441 · Cited by 142
Shvedova, A. A., Yanamala, N. V. K., Kisin, E. R., Tkach, A. V., Murray, A. R., Hubbs, A. F., Chirila, M. M., Keohavong, P., Sycheva, L. P., Kagan, V. E., et al. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00167.2013 · Cited by 124
SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma
Jeong, S. M., Lee, A., Lee, J., & Haigis, M. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525949 · Cited by 121
Titanium dioxide nanoparticles impair lung mitochondrial function
Freyre‐Fonseca, V., Delgado‐Buenrostro, N. L., Gutiérrez-Cirlos, E. B., Calderón-Torres, C. M., Cabellos-Avelar, T., Sánchez-Pérez, Y., Pinzón, E., Torres, I., Molina‐Jijón, E., & Zazueta, C. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.01.025 · Cited by 123
Song, I.-S., Jeong, Y. J., Jeong, S. H., Heo, H. J., Kim, H. K., Bae, K. B., Park, Y., Kim, S. U., Kim, J., Kim, N., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.007 · Cited by 123
Glucose Metabolism in Pancreatic Cancer
Liang, Y., Raj, P. S., Yao, W., & Ying, H. (2019) · Cancers · doi:10.3390/cancers11101460 · Cited by 127
Mitochondria as a target in cancer treatment
Liu, Y., & Shi, Y. (2020) · MedComm · doi:10.1002/mco2.16 · Cited by 120
Policastro, L. L., Ibañez, I. L., Notcovich, C., Duran, H. A., & Podhajcer, O. L. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4367 · Cited by 120
Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR
Deng, P., & Haynes, C. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.002 · Cited by 121
A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase
Kirova, D., Judasová, K., Vorhauser, J., Zerjatke, T., Leung, J. K., Glauche, I., & Mansfeld, J. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.06.008 · Cited by 125
The complex landscape of pancreatic cancer metabolism
Sousa, C. M., & Kimmelman, A. C. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu097 · Cited by 125
Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer
Dasgupta, B., & Chhipa, R. R. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.007 · Cited by 121
Pardee, T. S., Lee, K. C., Luddy, J. S., Maturo, C., Rodriguez, R., Isom, S. P., Miller, L. D., Stadelman, K. M., Levitan, D. A., Hurd, D. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1019 · Cited by 121
Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions
Xu, X. J., Meng, Y., Li, L., Xu, P., Wang, J., Li, Z., & Bian, J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00961 · Cited by 118
Hu, S., Feng, J., Wang, M., Wufuer, R., Liu, K., Zhang, Z., & Zhang, Y. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102470 · Cited by 123
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Zhao, Z., Mei, Y., Wang, Z., & He, W. (2022) · Cancers · doi:10.3390/cancers15010062 · Cited by 128
RAS signaling in carcinogenesis, cancer therapy and resistance mechanisms
Yang, X., & Wu, H. K. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01631-9 · Cited by 133
Metabolic Regulation of Redox Balance in Cancer
Purohit, V., Simeone, D. M., & Lyssiotis, C. A. (2019) · Cancers · doi:10.3390/cancers11070955 · Cited by 121
Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
Vaghari‐Tabari, M., Ferns, G. A., Qujeq, D., Andevari, A. N., Sabahi, Z., & Moein, S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30276 · Cited by 126
Oxidative Stress in Cancer Therapy: Friend or Enemy?
Azmanova, M., & Pitto‐Barry, A. (2022) · ChemBioChem · doi:10.1002/cbic.202100641 · Cited by 123
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway
Yuan, L., Sheng, X., Willson, A. K., Roque, D. R., Stine, J. E., Guo, H., Jones, H. M., Zhou, C., & Bae-Jump, V. L. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0192 · Cited by 116
Dysregulation of mitophagy in carcinogenesis and tumor progression
Chang, J. Y., Yi, H., Kim, H.-W., & Shong, M. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.12.008 · Cited by 117
Hollinshead, K. E. R., Parker, S. J., Eapen, V. V., Encarnación-Rosado, J., Sohn, A. S. W., Oncu, T., Cammer, M., Mancias, J. D., & Kimmelman, A. C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108231 · Cited by 118
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
Wang, H., Wang, L., Zhang, Y., Wang, J., Deng, Y., & Lin, D. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0280-y · Cited by 113
Toda, K., Kawada, K., Iwamoto, M., Inamoto, S., Sasazuki, T., Shirasawa, S., Hasegawa, S., & Sakai, Y. (2016) · Neoplasia · doi:10.1016/j.neo.2016.09.004 · Cited by 113
Structure, mechanism, and regulation of mitochondrial DNA transcription initiation
Basu, U., Bostwick, A. M., Das, K., Dittenhafer‐Reed, K. E., & Patel, S. S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011202 · Cited by 114
Jeong, S. M., Hwang, S., & Seong, R. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.023 · Cited by 112
Profiling metabolic networks to study cancer metabolism
Hiller, K., & Metallo, C. M. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.11.001 · Cited by 113
Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming
D’Alessandro, A., Kasmi, K. C. E., Plecitá‐Hlavatá, L., Ježek, P., Li, M., Zhang, H., Gupte, S. A., & Stenmark, K. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7217 · Cited by 111
An emerging role of PARK2 in cancer
Xu, L., Lin, D., Yin, D., & Koeffler, H. P. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1107-0 · Cited by 114
Chang, C.-W., Chen, Y., Chou, S.-H., Han, C., Chen, Y., Yang, C.-C., Huang, C., & Lo, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0626 · Cited by 113
Porporato, P. E., Payen, V. L., Baselet, B., & Sonveaux, P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2100-2 · Cited by 115
Hanot, M., Tubeuf, E., Guilbert, A., Bado‐Nilles, A., Vigneron, P., Trouiller, B., Braun, A., & Lacroix, G. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.01.013 · Cited by 110
Cheng, G., Zielonka, M., Dranka, B. P., Kumar, S. N., Myers, C. R., Bennett, B., Garces, A. M., Machado, L. G. D. D., Thiébaut, D., Ouari, O., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003044 · Cited by 113
Self-citationAltered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
Mohamed, A., Deng, X., Khuri, F. R., & Owonikoko, T. K. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.09.001 · Cited by 111
Metabolism strikes back: metabolic flux regulates cell signaling: Figure 1.Preprint
Metallo, C. M., & Heiden, M. G. V. (2010) · Genes & Development · doi:10.1101/gad.2010510 · Cited by 113
Wu, C.-A., Chao, Y., Shiah, S., & Lin, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.025 · Cited by 111
Opposing effects of TIGAR- and RAC1-derived ROS on Wnt-driven proliferation in the mouse intestinePreprint
Cheung, E. C., Lee, P., Ceteci, F., Nixon, C., Blyth, K., Sansom, O. J., & Vousden, K. H. (2015) · Genes & Development · doi:10.1101/gad.271130.115 · Cited by 114
Hüttemann, M., Lee, I., Grossman, L. I., Doan, J. W., & Sanderson, T. H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3573-0_10 · Cited by 111
Yang, L., Zhang, M., Dorfman, R. G., Pan, Y., Tang, D., Xu, L., Zhao, Z., Zhou, Q., Zhou, L., Wang, Y., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.03.008 · Cited by 107
Liu, Z., Gu, S., Lu, T., Wu, K., Li, L., Dong, C., & Zhou, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01646-3 · Cited by 108
ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
Gregory, M. A., D’Alessandro, A., Calderon, F. A., Kim, J., Nemkov, T. G., Adane, B., Rozhok, A. I., Kumar, A., Kumar, V., Pollyea, D. A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603876113 · Cited by 108
Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy
Caino, M. C., & Altieri, D. C. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0460 · Cited by 105
Zhang, X., Li, Z., Xuan, Z., Xu, P., Wang, W., Chen, Z., Wang, S., Sun, G., Xu, J., & Xu, Z. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0993-y · Cited by 106
RetractedCurcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1320-y · Cited by 106
Mitochondrial Localization of Telomeric Protein TIN2 Links Telomere Regulation to Metabolic Control
Chen, L., Zhang, Y., Zhang, Q., Li, H., Luo, Z., Fang, H., Kim, S. H., Qin, L., Yotnda, P., Xu, J., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.07.002 · Cited by 109
Kawada, K., Nakamoto, Y., Kawada, M., Hida, K., Matsumoto, T., Murakami, T., Hasegawa, S., Togashi, K., & Sakai, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1909 · Cited by 107
The Hallmarks of Cancer from a Redox Perspective
Hornsveld, M., & Dansen, T. B. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6580 · Cited by 105
Cancer resistance and metastasis are maintained through oxidative phosphorylation
Uslu, C., Kapan, E., & Lyakhovich, A. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216705 · Cited by 112
Electron transport chain inhibition increases cellular dependence on purine transport and salvage
Wu, Z., Bezwada, D., Cai, F., Harris, R. C., Ko, B., Sondhi, V., Pan, C., Vu, H., Nguyen, P. T., Faubert, B., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.014 · Cited by 101
Hielscher, A. C., & Gerecht, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.015 · Cited by 110
Metadata
- Authors
- Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care, Department of Medicine,
- Medical College of Wisconsin (US)
- Department of Biophysics and Free Radical Research Center, Medical College of Wisconsin, Milwaukee, WI 53226
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-26
- Volume
- 107
- Issue
- 19
- Pages
- 8788-8793
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2889315
- OpenAlex
- W1982330633
- Cited by
- 1,742
- References
- 29
- Citations by year
- 2026: 63 · 2025: 100 · 2024: 124 · 2023: 122 · 2022: 149 · 2021: 154 · 2020: 137 · 2019: 138 · 2018: 111 · 2017: 108 · 2016: 100 · 2015: 113 · 2014: 89 · 2013: 77 · 2012: 77
- FWCI
- 23.58
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000201)
- LUNGevity Foundation
- Respiratory Health Association of Metropolitan Chicago
- Respiratory Health Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL071643)
- National Cancer Institute (R01CA125112, R01CA152810, R01CA123067, CA125112, P30CA060553, T32CA070085, T32CA009560)
- National Institute of Environmental Health Sciences (ES 013995, ES015024, R01ES013995, R01ES015024)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- KRAS, mitochondrial metabolism, reactive oxygen species, pentose phosphate pathway, aerobic glycolysis, Warburg effect, anchorage-independent growth, glutaminase, alpha-ketoglutarate, TCA cycle, ERK signaling, mitochondrial complex III, TFAM, lung cancer, carcinogenesis, hypoxia
- MeSH terms
- Aerobiosis, Animals, Cell Adhesion, Cell Transformation, Neoplastic, Glutamine, Glycolysis, Humans, Lung Neoplasms, Mitochondria, Oxidative Phosphorylation, Pentose Phosphate Pathway, Electron Transport Complex III, Proto-Oncogene Proteins p21(ras), Reactive Oxygen Species, HCT116 Cells, Extracellular Signal-Regulated MAP Kinases, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
